SQUAMOUS CELL CARCINOMA ANTIGEN-DERIVED PEPTIDE BINDING TO HLA-A24 MOLECULE

摘要

Provided is a squamous cell carcinoma antigen derived peptide which is capable of binding to an HLA-A24 molecule and recognized by the cellular immune system, and a pharmaceutical composition comprising said peptide for the treatment or prevention of squamous cell carcinoma.